Managing Hypertension
For most adults with confirmed hypertension (BP ≥140/90 mmHg), initiate combination pharmacological therapy with a RAS blocker (ACE inhibitor or ARB) plus either a calcium channel blocker or thiazide diuretic, preferably as a single-pill combination, while simultaneously implementing lifestyle modifications targeting weight loss, sodium restriction, DASH diet, regular exercise, and alcohol moderation. 1, 2
Initial Diagnosis and Assessment
Confirm the diagnosis properly before committing patients to lifelong therapy:
- Measure BP using validated automated upper arm cuff devices with appropriate cuff size, taking at least two measurements per visit over multiple visits 3, 2
- Confirm diagnosis with home BP monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) 1, 2
- Measure BP in both arms at first visit; use the higher reading 1
- Check standing BP in elderly patients and those with diabetes to assess for orthostatic hypotension 3
Complete initial workup to identify target organ damage and cardiovascular risk:
- Urinalysis for blood and protein 2
- Serum electrolytes, creatinine, glucose, and lipid profile 2
- 12-lead ECG 2
- Calculate 10-year cardiovascular disease risk 3, 2
Lifestyle Modifications: The Foundation for All Patients
Implement these evidence-based interventions for every hypertensive patient, regardless of whether drug therapy is initiated: 3, 1
Weight Management
- Target BMI 20-25 kg/m² and waist circumference <102 cm (men) or <88 cm (women) 1, 2
- Each 1 kg weight loss reduces systolic BP by approximately 1 mmHg 2
Dietary Interventions
- DASH diet: Emphasize fruits, vegetables, whole grains, low-fat dairy, reduced saturated fat—reduces systolic BP by 5-8 mmHg 3, 2
- Sodium restriction: Limit to <2,300 mg/day (approximately 5-6 g salt)—reduces systolic BP by 2-8 mmHg 3, 1, 2
- Potassium supplementation: Increase dietary potassium intake through fruits and vegetables 3, 1
- Eliminate table salt use 3
Alcohol Moderation
- Men: ≤2 standard drinks per day (maximum 14/week) 3, 1
- Women: ≤1 standard drink per day (maximum 7-9/week) 3, 1
- Include alcohol-free days each week 3
- One standard drink = 14 g pure alcohol (12 oz beer, 5 oz wine, or 1.5 oz spirits) 3
Physical Activity
- Minimum 150 minutes/week of moderate aerobic exercise (30 minutes on 5-7 days/week) 1, 2, 4
- Add resistance training 2-3 times/week 2
- Exercise reduces systolic BP by 4-9 mmHg 2
- Post-exercise hypotension continues up to 24 hours 4
Smoking Cessation
- Mandatory recommendation with appropriate support and assistance 1
Pharmacological Therapy: When and How to Initiate
Treatment Thresholds
Immediate drug therapy is indicated for: 3, 2
- Sustained BP ≥160/100 mmHg regardless of cardiovascular risk 3
- Sustained BP 140-159/90-99 mmHg with any of the following:
- BP ≥130/80 mmHg with high cardiovascular risk 2
For malignant hypertension or hypertensive emergency, initiate treatment immediately without delay. 3
First-Line Combination Therapy
The modern approach prioritizes combination therapy from the start for most patients: 1, 2
Preferred initial combinations: 1, 2
- ACE inhibitor (e.g., lisinopril) + dihydropyridine calcium channel blocker (e.g., amlodipine) 1, 5, 6
- ACE inhibitor or ARB + thiazide/thiazide-like diuretic (e.g., chlorthalidone) 1, 7
- Calcium channel blocker + thiazide/thiazide-like diuretic 1
Use fixed-dose single-pill combinations to improve adherence. 1, 2
Critical Pitfall to Avoid
Never combine two RAS blockers (ACE inhibitor + ARB) as this increases harm without additional benefit. 1
Escalation Strategy
If BP target not achieved with dual therapy: 2
- Progress to triple therapy: ACE inhibitor/ARB + calcium channel blocker + thiazide/thiazide-like diuretic 2
- Consider adding mineralocorticoid receptor antagonist (e.g., spironolactone) as fourth agent for resistant hypertension 8
Special Population Considerations
Black patients from African descent: 3, 1
- First-line: Thiazide diuretic + calcium channel blocker, OR calcium channel blocker + ARB 3, 1
- ARBs preferred over ACE inhibitors (3-fold lower risk of angioedema) 3
- Annual screening recommended for adults ≥18 years 3
- Emphasize salt restriction and increased potassium intake 3
Elderly patients: 1
- Initiate at lower doses and titrate gradually 1
- Monitor carefully for orthostatic hypotension 1
- Intensive BP control may help prevent cognitive decline 1
Patients with diabetes, CKD, or established CVD: 3, 1
Blood Pressure Targets
Target BP varies by patient characteristics: 3, 1
- Most adults <65 years: 120-129/70-79 mmHg 1
- Adults ≥65 years: Systolic <130 mmHg 1
- Diabetes, CKD, or established CVD: ≤130/80 mmHg 3, 1
- CKD with eGFR >30 mL/min/1.73 m²: 120-129 mmHg systolic 1
- Stroke or TIA history: 120-130 mmHg systolic 1
Note: Home and ambulatory BP readings run approximately 10/5 mmHg lower than office readings; adjust targets accordingly 3
Monitoring and Follow-Up
Structured follow-up is essential for achieving and maintaining control:
- Monthly visits until BP target achieved (goal: within 3 months) 1, 2
- Utilize home BP monitoring to guide medication adjustments 1, 2
- Monitor serum creatinine and potassium 2-4 weeks after initiating or changing doses of ACE inhibitors, ARBs, or aldosterone antagonists 1
- Once controlled, consider 90-day medication refills rather than 30-day to improve adherence 2
Clinical Outcomes: Why This Matters
The evidence for BP control is unequivocal: 7
- Each 10 mmHg reduction in systolic BP decreases cardiovascular events by 20-30% 7
- Effective BP control reduces stroke incidence by 35-40%, myocardial infarction by 20-25%, and heart failure by 50% 2
- For every 12 mmHg systolic BP reduction maintained over 10 years, one death is prevented for every 11 treated patients with additional cardiovascular risk factors 2
- Even a 5 mmHg reduction decreases coronary heart disease mortality by 9%, stroke mortality by 14%, and all-cause mortality by 7% 4
Common Pitfalls and How to Avoid Them
Do not delay treatment in young adults with hypertension—they have earlier onset of cardiovascular events compared to those with normal BP 1
Do not withhold treatment due to asymptomatic orthostatic hypotension—this is not associated with higher rates of cardiovascular events 1
Improve medication adherence through once-daily dosing and fixed-dose combinations rather than blaming patients for "non-compliance" 1
Do not rely solely on office BP measurements for diagnosis or treatment decisions—confirm with home or ambulatory monitoring 1, 2
Team-based care is the most effective approach for achieving BP control, incorporating nurses, pharmacists, and other health professionals with home BP monitoring and telemonitoring 2